The Case Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1826-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.case.edu/cancer
Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors
- Conditions
- Moderate DepressionBreast Cancer FemaleBreast Cancer Stage IBreast CancerBreast Cancer Stage IIBreast Cancer Stage IIIMild Depression
- Interventions
- Other: MBCT
- First Posted Date
- 2024-03-28
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 31
- Registration Number
- NCT06336538
- Locations
- 🇺🇸
Cleveland Clinic Department of Wellness and Preventive Medicine, Cleveland, Ohio, United States
Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy
- Conditions
- Malignant Neoplasm of BladderMuscle Invasive Bladder Carcinoma
- Interventions
- Drug: Neoadjuvant ChemotherapyProcedure: Partial cystectomy with Extended pelvic lymph node dissectionDrug: Adjuvant systemic therapy
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT06290687
- Locations
- 🇺🇸
Glickman Urological and Kidney Institute, Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
- Conditions
- Urothelial Carcinoma
- Interventions
- Procedure: NephroureterectomyProcedure: Lymph Node Dissection
- First Posted Date
- 2024-02-16
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 94
- Registration Number
- NCT06262516
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Urology Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland, Ohio, United States
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- Conditions
- Gastrointestinal CancerAnal CancerEsophageal CancerAppendix CancerLiver CancerStomach CancerRectal CancerPancreas CancerColon CancerNeuroendocrine Tumors
- Interventions
- Other: EQUITY GI
- First Posted Date
- 2024-02-16
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 200
- Registration Number
- NCT06263088
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery
- Conditions
- Skin CancerSkin Carcinoma
- Interventions
- Other: WaterOther: Lavender essential oil
- First Posted Date
- 2023-12-12
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 100
- Registration Number
- NCT06167096
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
- Conditions
- Prostate CancerSecondary Malignant Neoplasm of ProstateMalignant Neoplasm of Prostate
- Interventions
- Drug: Androgen deprivation therapy (ADT)Drug: Androgen receptor signaling inhibitor (ARSI)Radiation: Metastasis directed radiotherapy (MDRT)
- First Posted Date
- 2023-11-29
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 200
- Registration Number
- NCT06150417
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland, Ohio, United States
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
- Conditions
- Tumor, BreastBreast Cancer
- Interventions
- Radiation: Radiation Therapy
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 55
- Registration Number
- NCT06129747
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Glioblastoma Remote Monitoring and Care - Research Protocol
- Conditions
- Venous ThromboembolismGlioblastomaSeizures
- Interventions
- Device: Apple Watch
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT06129760
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)
- First Posted Date
- 2023-10-31
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Case Comprehensive Cancer Center
- Registration Number
- NCT06110598
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Development of MRF for Characterization of Brain Tumors After Radiotherapy
- Conditions
- Brain MetastasesBrain TumorBrain NecrosisGlioma
- Interventions
- Procedure: MRF in conjunction with IVIM MRI without contrast
- First Posted Date
- 2023-10-25
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT06101069
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States